Abveris on-demand webinar 08/25/2021

Discovery of High-Quality Anti-Idiotypic mAbs (Anti-Id) for Development of Critical PK/ADA Assay Reagents

Speaker

Ryan Kelly, Head of Business Development 

Topics of Discussion

Anti-Idiotypic antibodies (anti-Id) are critical assay reagents used in PK/ADA assays for therapeutic biologics entering clinical trials. Ensuring the timely readiness of high-quality, assay-ready anti-Id is a top-priority task for all bioanalytical groups. In this webinar, the Abveris team will discuss how to de-risk anti-Id discovery in terms of screening platform and strategy selection.

1. Key attributes for an industry-leading reagent antibodies discovery engine
2. Discovery campaign designs for anti-Ids against different therapeutic biologics illustrated by case studies